Riskpilot← Back to searchSign inGet full accessFalkenbergkliniken Tandvård AB
ABDissolvedOrg 5567976237Dental practice care activities · NACE 8623Est. 20090 employees
Revenue 2021
SEK 11,9M
-5% vs 2020
EBITDA margin
15.9%
-8% vs 2020
Equity ratio
4.9%
Financial strength
Net profit 2021
SEK 5K
+150% vs 2020
| Revenue | SEK 11,9M | -5% |
| EBITDA | SEK 1,9M | -8% |
| Net profit | SEK 5K | +150% |
| Total assets | SEK 3,2M | +4% |
| Equity | SEK 157K | +3% |
| Employees | 0 | — |
Legal name
Falkenbergkliniken Tandvård AB
Org number
5567976237
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
17 december 2009
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av en av ledamöterna i förening med Holck, Daniel eller en av dem i förening med Løfsnæs, Silje Drege Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är att bedriva tandläkarverksamhet och utbildningsverksamhet i anslutning härtill samt förvalta fast egendom och värdepapper, ävensom idka därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 6 021 | 8 041 | 10 312 | 12 609 | 11 943 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 996 | 689 | 626 | 2 067 | 1 900 |
| Depreciation & amort. | −58 | −71 | −53 | −53 | −543 |
| EBIT | 938 | 618 | 573 | 2 014 | 1 357 |
| Net financials | −9 | −4 | −13 | −4 | −11 |
| Profit before tax | 29 | 2 | 2 | 4 | 6 |
| Tax | −7 | −1 | −1 | −2 | −1 |
| Net profit | 22 | 1 | 1 | 2 | 5 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 1 097 | 2 312 | 3 044 | 3 085 | 3 215 |
| Equity | 149 | 150 | 150 | 153 | 157 |
| Long-term debt | 0 | 0 | 0 | 0 | 292 |
| Short-term debt | 948 | 2 163 | 2 893 | 2 933 | 2 766 |
| Total debt | 948 | 2 163 | 2 893 | 2 933 | 3 058 |
EBITDA margin
15.9%
This company
15.8%
Market median
+1% vs market
20172021
Equity ratio
4.9%
This company
38.2%
Market median
-87% vs market
20172021
Return on equity
3.2%
This company
18.4%
Market median
-83% vs market
20172021
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20172021
Asset turnover
3.71×
This company
1.12×
Market median
+231% vs market
20172021
Debt / equity
19.48×
This company
0.62×
Market median
-3042% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LC | Audit | 2020 |
CM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2020 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Falkenbergkliniken Tandvård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars-Inge Christer Persson | Audit | 0 companies |
| Carl Marcus Christopher Dagnelid | Chief Executive Officer | 0 companies |
| Niclas Johan Victor Dagnelid | Board of Directors | 0 companies |
| Daniel Holck | Chairman | 0 companies |
| Silje Drege Løfsnes | Board of Directors | 0 companies |